Article
Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer.
Biochemical and biophysical research communications - 24 Oct 2003
Rao Prema S, Jaggi Meena, Smith David J, Hemstreet George P, Balaji K C
Abstract excerpt
Prostate cancer (PC) patients die from progression to androgen independence (AI) and chemoresistance (CR). Protein kinase Cmu (PKCmu) a novel member of the PKC family of signal transduction proteins is downregulated in AI PC. Studying PKCmu interactors in the yeast two-hybrid system identified metallothionein 2A (MT 2A) as an interactor of PKCmu kinase domain (KD) in PC, which was quantified by beta-gal assay,...
Topics
Join the communities discussing this publication.
